Postpartum HemorrhageNCT04027920
Postpartum Hemorrhage After Shenghua Decoction Treatment
An observational study of Postpartum Hemorrhage, run by Far Eastern Memorial Hospital at 1 site in Taiwan.
Trial summary
A rare case of disastrous delayed postpartum hemorrhage after three days of shenghua decoction treatment. Read more about this study
- Who is it for?
- Ages 20 years and older, women only
- Conditions the study is for
- Postpartum Hemorrhage
- What is being tested?
- Shenghua Decoction
- How many people
- 1 participants
- Where
- 1 siteTaiwan
- Study dates
- 2 May 2019to 17 Jun 2019
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 years and older
- Women only
- No healthy volunteers
- Adult, Older adult
Study population: A postpartum woman with delayed pospartum hemorrhage
Who may be able to join
- Postpartum hemorrhage after shenghua decoction treatment.
Who cannot join
- Nil
Trial locations and contacts
1 site in 1 country.
Taiwan1 site
Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital
Banqiao District, New Taipei, 22050
About this study
Official title: Disastrous Delayed Postpartum Hemorrhage After Three Days of Shenghua Decoction Treatment: a Case Report
A rare case of disastrous delayed postpartum hemorrhage after three days of shenghua decoction treatment.
Read the detailed description
A rare case of disastrous delayed postpartum hemorrhage after three days of shenghua decoction treatment.
- Conditions
- Postpartum Hemorrhage
- Being tested
- Shenghua Decoction
- Keywords
- postpartum hemorrhage
- Medical subject headings
- Postpartum Hemorrhage
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Shenghua DecoctionDrug
Three days' shenghua decoction treatment
What is being measured
The primary outcome is the main question the study is designed to answer.
Presence of postpartum hemorrhage or not
Presence of postpartum hemorrhage or not, following three days of shenghua decoction treatment. The total estimated blood loss was approximately 2000 mL at that time. Her hemoglobin was revealed to be 2.6 g/dL, her hematocrit was 8.5%, and the vaginal bleeding persisted despite medications, so emergency total hysterectomy was performed.
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Jul 2019
- Study start2 May 2019
- Primary completion17 Jun 2019
- Study completion17 Jun 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Postpartum HemorrhageStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Retrospective
- Enrolment
- 1 participants (actual)
Sponsor and investigators
- Lead sponsor
- Far Eastern Memorial Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Sheng-Mou Hsiao, Far Eastern Memorial Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04027920
- Sponsor's protocol ID
- 108046-C
- Status last verified
- Jul 2019
- First submitted
- 12 Jul 2019
- Last updated
- 2 Jun 2020
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 2 Jun 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Disastrous Delayed Postpartum Hemorrhage After Three Days of Shenghua Decoction Treatment: a Case Report
- ClinicalTrials.gov ID
- NCT04027920
- Acronym / sponsor ID
- 108046-C
- Conditions
- Postpartum Hemorrhage
- Keywords
- postpartum hemorrhage
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1 participants (actual)
- Lead sponsor
- Far Eastern Memorial HospitalUniversity, hospital or other
- Study start
- 2 May 2019 (actual)
- Primary completion
- 17 Jun 2019 (actual)
- Study completion
- 17 Jun 2019 (actual)
- First posted
- 22 Jul 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A rare case of disastrous delayed postpartum hemorrhage after three days of shenghua decoction treatment.
Detailed description
A rare case of disastrous delayed postpartum hemorrhage after three days of shenghua decoction treatment.
Study design
- Observational model
- Case only
- Time perspective
- Retrospective
Who may qualify
- Ages
- 20 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- A postpartum woman with delayed pospartum hemorrhage
Key inclusion criteria (1 listed)
- Postpartum hemorrhage after shenghua decoction treatment.
Key exclusion criteria (1 listed)
- Nil
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Shenghua DecoctionThree days' shenghua decoction treatment | Drug | – |
Primary outcome
Presence of postpartum hemorrhage or not
Time frame: 1 year
Presence of postpartum hemorrhage or not, following three days of shenghua decoction treatment. The total estimated blood loss was approximately 2000 mL at that time. Her hemoglobin was revealed to be 2.6 g/dL, her hematocrit was 8.5%, and the vaginal bleeding persisted despite medications, so emergency total hysterectomy was performed.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Jun 2020.
- Individual participant dataSharing planned: Undecided
Related trials for Postpartum Hemorrhage
RecruitingPhase 3
Tranexamic Acid to Prevent Heavy Bleeding After Childbirth in Women at Higher Risk
Postpartum Hemorrhage
Not yet recruitingObservational study
Measured Versus Hemoglobin-Calculated Postpartum Blood Loss in Waterbirth
Postpartum Hemorrhage, Waterbirth
RecruitingObservational study
Long Term Outcome After Use of Vacuum-induced Tamponade for Postpartum Hemorrhage
Postpartum Hemorrhage, Treatment Outcome
RecruitingPhase 2
Prevention of Postpartum Hemorrhage With Tranexamic Acid
Post Partum Hemorrhage
RecruitingObservational study
Hemoglobin Testing in Pregnant Patients
Post Partum Hemorrhage, Anemia of Pregnancy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Postpartum Hemorrhage, run by Far Eastern Memorial Hospital at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 2 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Presence of postpartum hemorrhage or not (time frame: 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jun 2020; AzTrials last refreshed its copy on 6 Nov 2026.